8th Annual Neuro-Oncology Review Course
November 15, 2023


              

This activity is provided by the Society for Neuro-Oncology

Target Audience
Practicing physicians, residents and fellows, medical students, nurse practitioners, nurses, and all those interested in reviewing and enhancing their knowledge in the principles of clinical Neuro-Oncology.

Statement of Need/Program Overview
The Neuro-Oncology Review Course was developed to provide junior neuro-oncologists, fellows, residents, nurse practitioners and physician assistants who attend the SNO Education Day and Scientific Meeting with a concise overview of Neuro-Oncology clinical knowledge, as well as preparation for Neuro-Oncology and oncology boards.  SNO membership includes nationally and internationally recognized leaders in the field and will provide faculty for the program. The United Council for Neurologic Subspecialties (UCNS), a nonprofit organization that accredits training programs (fellowships) in neurologic subspecialties and awards certification to physicians who demonstrate their competence in these subspecialties, has developed a Core Curriculum for Neuro-Oncology Certification. This Core Curriculum helped to guide development of the content of this review course. Content was designed to fulfill the curriculum elements while avoiding undue duplication with the SNO Education Day and Scientific Program.

Educational Objectives

After participating in this CME activity, participants should be able to: 

• Describe multidisciplinary treatment modalities for the management of primary and secondary central nervous system tumors using updated brain tumor classifications.
• Identify the signs and symptoms of medical complications affecting Neuro-Oncology patients.
• Compare central nervous system tumors and associated challenges caring for patients across different ages including infancy, pediatric, adolescent/young adult, and geriatric.
• Discover strategies to integrate supportive and palliative care into the care of patients with primary and metastatic cancers of the central nervous system.
• Outline the basics of clinical trials in neuro-oncology including trial design, recruitment, and basic biostatistics.
• Identify genetic predisposition syndromes in central nervous system tumors.

Program Agenda
Please click here.

Physician Accreditation Statement
The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation
The Society for Neuro-Oncology designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SNO CME Contact Information

For more information about the accreditation of this program, please contact the Society for Neuro-Oncology CME Program Manager, MeLesa Ritterhouse, RN at melesa@soc-neuro-onc.org.

Instructions to Receive Credit
In order to receive credit for this activity, the participant must have attended the sessions in-person (you cannot claim CME for on-demand sessions), complete the review evaluation and session evaluations by logging in to this website or the conference mobile app by using the users registration login. 

Click here for step-by-step instructions.

Deadline to claim CE Credit is Monday, February 12th, 2024.

Refund/Cancellation Policy
The deadline for cancellations with refund is Thursday, November 2, 2023. Cancellations must be received in writing and a $50 cancellation fee will be assessed. Cancellations received after the deadline date cannot be refunded, but the meeting registration can be transferred to another person with written authorization..

Please note that your SNO membership must be current if you have chosen to register as a SNO member. SNO reserves the right to confirm that you have registered in the correct category.

 

Payment must be received in full before access to the meeting can be granted.

Email all cancellation and transfer requests to Program Registrar Caroline Noor, caroline@soc-neuro-onc.org.

Disclosure of Relevant Financial Relationships

The Society for Neuro-Oncology (SNO) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited Continuing Education, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of accredited continuing education program are required to disclose all financial relationships with any ineligible company within the past 24 months . All financial relationships reported are identified as relevant and mitigated by Society for Neuro-Oncology in accordance with the Standards for Integrity and Independence in Accredited Continuing Education in advance of delivery of the activity to learners. The content of this activity has been vetted to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by SNO.

Please find the list of disclosures here. 

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Society for Neuro-Oncology does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.